PMI and BAT Resolve Intellectual Property Dispute

BATPMI by 2FIRSTS.ai
Feb.03.2024
PMI and BAT Resolve Intellectual Property Dispute
Philip Morris International (PMI) and British American Tobacco (BAT) have resolved their intellectual property dispute over heated tobacco and e-cigarette products.

On February 2nd, in the Eastern Time Zone of the United States, both Philip Morris International (PMI) and British American Tobacco (BAT) announced on their respective official websites that they have resolved their intellectual property dispute regarding heated tobacco and e-cigarette products.

 

PMI and BAT Resolve Intellectual Property Dispute
PMI Press Release | Image Source: PMI Official Website

 

British American Tobacco (BAT) and Philip Morris International (PMI) have announced a settlement agreement that includes non-monetary terms between the two companies. This agreement resolves all ongoing global patent infringement lawsuits, including any related injunctions and exclusions, and prevents future claims against current heated tobacco and vaping products. The settlement also allows both parties to continue innovating and launching improved versions of their products. Both companies are committed to ongoing innovation in the reduced-risk product space, furthering efforts to reduce the harm caused by tobacco.

 

PMI and BAT Resolve Intellectual Property Dispute
BAT News Just In | Image Source: BAT Official Website.

 

These two international tobacco companies have been embroiled in a multifaceted patent war. BAT's e-cigarette brand VUSE and heat-not-burn tobacco device brand GLO suffered a defeat in one case, being ordered to pay millions of dollars; while PMI was prohibited from introducing its flagship heat-not-burn tobacco device IQOS into the United States due to another lawsuit.

 

PMI CEO, Jacek Olczak, expressed satisfaction with the resolution, stating, "We are pleased that both parties are content with the outcome. Adult smokers worldwide consistently display a desire for a range of smoke-free products, and we believe that continued innovation in reduced-risk alternatives can expedite the reduction of smoking-related harms, benefiting consumers and public health as a whole. Meanwhile, we will remain committed to phasing out the sale of traditional cigarettes as part of PMI's journey.

 

BAT CEO Tadeu Marroco has expressed his satisfaction with the recent agreement, stating, "This agreement is a significant step forward for BAT and all our stakeholders. With the successful development of our billion-pound brands VUSE and GLO, the potential for reducing tobacco harm is evident. I am pleased that this settlement will allow BAT to focus on developing innovative solutions to provide adult consumers with reduced-risk products and contribute to our 'A Better Tomorrow' mission. By doing so, we will help build a smoke-free world for consumers, investors, and society as a whole."

 

2FIRSTS has invited Chinese e-cigarette legal expert Counsellor Tang Shunliang to provide a professional analysis of the background and potential impact of the patent settlement between PMI and BAT. An article providing this analysis will be published later. Stay tuned.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Singapore Installs E-cigarette Disposal Bins to Prevent Etomidate Abuse
Singapore Installs E-cigarette Disposal Bins to Prevent Etomidate Abuse
Singapore launched the “Bin the Vape” program with 24 secure bins to prevent misuse of e-cigarettes possibly containing etomidate. With the drug soon classified as Class C, stricter penalties include rehab for users, jail for repeat offenders, and up to 20 years’ imprisonment for sellers.
Jul.29 by 2FIRSTS.ai
2Firsts Exclusive: Dr. Zdinak Analyzes FDA’s Rejection of blu, Citing Lack of Behavioral Evidence
2Firsts Exclusive: Dr. Zdinak Analyzes FDA’s Rejection of blu, Citing Lack of Behavioral Evidence
In a 2Firsts exclusive, ARAC’s Dr. Zdinak explains FDA’s blu rejection stems from weak behavioral science data and urges companies to strengthen Module 6 studies immediately.
Aug.20
FDA Approval of Five Juul Products Sparks Controversy: Industry Calls It “Support for Quitting,” Critics Say It “Endangers Youth”
FDA Approval of Five Juul Products Sparks Controversy: Industry Calls It “Support for Quitting,” Critics Say It “Endangers Youth”
The U.S. FDA approved five Juul e-cigarette products, triggering controversy. Industry groups welcomed the move as a long-overdue step to support adult smokers switching from cigarettes, while tobacco control advocates condemned it as a setback for youth protection. Juul remains one of the most popular brands among teens.
Jul.23 by 2FIRSTS.ai
Gumipod Accuses Altria of Misusing Confidential Technology for “On!” Nicotine Pouches
Gumipod Accuses Altria of Misusing Confidential Technology for “On!” Nicotine Pouches
Gumipod Group, Ltd. files federal lawsuit against Altria Group for alleged theft of trade secrets in packaging "On!" nicotine pouches.
Aug.26 by 2FIRSTS.ai
Brazil: Americana Councilor Proposes Ban on Vaping in Public Places
Brazil: Americana Councilor Proposes Ban on Vaping in Public Places
On September 1, Wagner Rovina, a councilor in Americana, Brazil, submitted a bill to the city council proposing a ban on the use of electronic cigarettes in public places, including squares, parks, schools, restaurants, and cinemas. The proposal is expected to go to a vote soon. It aims to strengthen oversight, protect public health, and prevent underage vaping.
Sep.02 by 2FIRSTS.ai
Exclusive 2Firsts Contribution | Dr. Ziauddin Islam: Smoke-Free Pakistan — Dream or Reality?
Exclusive 2Firsts Contribution | Dr. Ziauddin Islam: Smoke-Free Pakistan — Dream or Reality?
This article, contributed by Dr. Ziauddin Islam, public health professional and former Focal Person of Pakistan to the WHO FCTC, reflects on Sweden’s achievement as the first “smoke free” nation. He argues Pakistan can learn from Sweden’s strict policies and harm reduction strategy, urging stronger enforcement, public awareness, and adoption of reduced-risk products to move toward a smoke free future.
Sep.01